A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
Clinical trial NCT06370728 · COMPLETED
Trial details
- NCT number
- NCT06370728
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-06
- Primary completion
- 2024-07-23
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.